MVA 85A
MVA 85A is a biological therapy with 7 clinical trials. Historical success rate of 100.0%.
Registry-listed formulations
This catalogue entry has no confirmed scientific concept.
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
0 source entries across 0 studies. This list may not include all unresolved or historical entries.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
100.0%
7 of 7 finished
0.0%
0 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV
A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both
Safety of Tuberculosis Vaccine, MVA85A, Administered by the Intramuscular Route and the Intradermal Route
Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines
Safety and Immunogenicity of MVA85A, in Healthy Volunteers in Cape Town
Clinical Trials (7)
The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV
A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both
Safety of Tuberculosis Vaccine, MVA85A, Administered by the Intramuscular Route and the Intradermal Route
Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines
Safety and Immunogenicity of MVA85A, in Healthy Volunteers in Cape Town
A Study of 2 Doses of a New TB Vaccine, MVA85A, in Healthy Volunteers Previously Vaccinated With BCG
Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB.
All 7 trials loaded
Drug Details
- Intervention Type
- Biological
- Total Trials
- 7